|Ms. Janelle D'Alvise||Pres, CEO, Corp. Sec. & Director||620.16k||N/A||1955|
|Dr. Pierre Lemieux M.D., Ph.D.||Co-Founder, COO & Chief Scientific Officer||398.75k||N/A||1965|
|Mr. Brian D. Ford CPA, CA||Chief Financial Officer||340.84k||N/A||1959|
|Dr. George Kottayil||Chief Operating Officer of US||160.16k||N/A||1963|
|Mr. Prashant Kohli||Chief Commercial Officer||185.2k||N/A||N/A|
|Dr. Yves Lachance Ph.D.||VP of Quality & Compliance||N/A||N/A||N/A|
|Ms. Christine Pelletier||Sr. Director of HR||N/A||N/A||N/A|
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.